Biomarker and animal models for assessment of retinoid efficacy in cancer chemoprevention

Acta Pharmacologica Sinica

Volumn 28, Issue 9, 2007, Pages 1383-1391

  Niles, Richard M ^a  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Animal models; Biomarkers; Chemoprevention; Retinoic acid; Transgenic animals; Vitamin A

Indexed keywords

BIOLOGICAL MARKER; DNA METHYLTRANSFERASE; RETINOIC ACID; RETINOID; RETINOL;

CANCER; CHEMOPROPHYLAXIS; DNA METHYLATION; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; LUNG CANCER; NONHUMAN; REVIEW; UTERINE CERVIX DYSPLASIA;

ANIMALS; ANTICARCINOGENIC AGENTS; HUMANS; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; TUMOR MARKERS, BIOLOGICAL; VITAMIN A;

EID: 34548379910     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2007.00685.x     Document Type: Review

References (103)

1. Hofmann C, Eichele G. Retinoids in development. In : Sporn M, Roberts AB, Goodman M, editors. The retinoids, biology, chemistry and medicine, 2nd ed. New York : Plenum Press 1994. p 387 441.
2. Eskild W, Hansson V. Vitamin A functions in the reproductive organs. In : R Blomhoff, editor. Vitamin A in health and disease. New York : Marcel Dekker 1994. p 531 9.
3. DeLuca LM. Retinoids and their receptors in differentiation, embryogenesis and neoplasia. FASEB J 1991 5 : 2924 33.
4. Wald G. The molecular basis of visual excitation. Nature 1968 219 : 800 07.
5. Thompson JN, Howell JM, Pitt GAJ. Vitamin A and reproduction in rats. Proc R Soc Lond B 1964 159 : 510 35.
6. Wolbach SB, Howe PR. Tissue changes following deprivation of fat-soluble A vitamin. Proc Soc Exp Biol Med 1925 77 : 825.
7. Lasnitzki I. The influence of hypervitaminosis on the effect of 20-methylcholanthrene on mouse prostate glands growth in vitro. Br J Cancer 1955 9 : 434 41.
8. Saffiotti U, Montessano R, Sellakumar AR, Borg SA. Experimental cancer of the lung: Inhibition by vitamin A of the induction of tracheobronchial squamous metaplasia and squamous cell tumors. Cancer 1967 20 : 857 64.
9. Kawaguchi R, Yu J, Honda J, Hu J, Whitelegge J, Ping P, et al. A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A. Science 2007 315 : 820 5.
10. Pasutto F. Stricht H, Hammersen G, Gillessen-Kaesbach G, Fitzpatrick DR, Nürnberg G, et al. Mutations in STRA6 cause a broad spectrum of malformations including anophthalmia, congenital heart defects, disphragmatic hernia, alveolar capillary dysplasia, lung hypoplasia, and mental retardation. Am J Hum Genet 2007 80 : 550 60.
11. Levin MS, Li E, Ong DE, Gordon JI. Comparison of the tissue-specific expression and developmental regulation of two closely linked rodent genes encoding cytosolic retinol-binding proteins. J Biol Chem 1987 262 : 7118 25.
12. Blaner WS, Das K, Mertz JR, Das SR, Goodman DS. Effects of dietary retinoic acid on cellular retinol- and retinoic acid-binding protein levels in various rat tissues. J Lipid Res 1986 27 : 1084 8.
13. Astrom A, Tavakkol A, Pattersson U, Cromie M, Elder JT, Voorhees JJ. Molecular cloning of two human cellular retinoic acid-binding proteins (CRABP). J Biol Chem 1991 266 : 17662 6.
14. Rajan N, Kidd GL, Tamage DA, Blaner WS, Suhara A, Godman DS. Cellular retinoic acid-binding protein messenger RNA levels in rat tissue and localization in rat testis. J Lipid Res 1991 32 : 1195 204.
15. Ross AC, Zolfaghari R, Weisz J. Vitamin A: recent advances in the biotransformation, transport, and metabolism of retinoids. Curr Opin Gastroenterol 2001 17 : 184 92.
16. Delva L, Bastie JN, Rochette-Egly C, Kraiba R, Balitrand N, Despouy G, et al. Physical and functional interactions between cellular retinoic acid binding protein II and the retinoic acid-dependent nuclear complex. Mol Cell Biol 1999 19 : 7158 67.
17. Budh AS, Noy N. Direct channeling of retinoic acid between cellular retinoic acid-binding protein II and retinoic acid receptor sensitizes mammary carcinoma cells to retinoic acid-induced growth arrest. Mol Cell Biol 2002 22 : 2632 41.
18. Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM, et al. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 1992 68 : 397 406.
19. Levin AA, Sturgenbeker LJ, Kazmer S, Bosakowski T, Huselton C, Allenby G, et al. 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXR Nature 1992 355 : 359 61.
20. Mangelsdorf DJ, Ong ES, Dyck JA, Evans RM. Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 1990 345 : 224 9.
21. Predke PF, Zamble D, Sarkar B, Giguere V. Ordered binding of retinoic acid and retinoid-X receptors to asymmetric response elements involves determinants adjacent to the DNA-binding domain. Mol Endocrinol 1994 8 : 31 9.
22. Carlsberg C, Bend I, Ways A, Meier E, Sturzenbecker LJ, Grippo JF, et al. Two nuclear signaling pathways for vitamin D. Nature 1993 361 : 657 60.
23. Kliewer SA, Umensono K, Mangelsdorf DJ, Evans RM. Retinoid X receptors interact with nuclear receptors in retinoic acid, thyroid hormone, and vitamin D3 signaling. Nature 1992 335 : 446 9.
24. Leid M, Kastner P, Lyons R, Nakshari H, Saunders M, Zacharewski T, et al. Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 1992 68 : 377 95.
25. Bugge TH, Pohl J, Lonnoy O, Stunnenberg HG. RXRγ, a promiscuous partner of retinoic acid and thyroid hormone receptors. EMBO J 1992 11 : 1409 10.
26. Keller H, Dreyer C, Medin J, Mahfoudi A, Ozato K, Wahli W. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferators-activated receptor-retinoid X receptor heterodimers. Proc Natl Acad Sci USA 1993 90 : 2160 4.
27. Kliewer SA, Umesono K, Noonan DJ, Heyman RA, Evans RM. Convergence of 9-cis retinoic acid and peroxisome proliferators signaling pathways through heterodimer formation of their receptors. Nature 1992 358 : 771 4.
28. Kliewer SA, Umesono K, Heyman RH, Mangelsdorf DJ, Dyck JA, Evands RM. Retinoid X receptor-COUP-TF interactions modulate retinoic acid signaling. Proc Natl Acad Sci USA 1992 89 : 1448 52.
29. Perlmann T, Jansson L. A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1. Genes Dev 1995 9 : 769 82.
30. Zhang XK, Hoffmann B, Tran PBV, Graupner G, Pfahl M. Ret-inoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature 1992 355 : 441 6.
31. Sucov HM, Murakami KK, Evans RM. Characterization of an autoregulated response element in the mouse retinoic acid receptor type β gene. Proc Natl Acad Sci USA 1990 5392 6.
32. Umesono K, Murakami KK, Thompson CC, Evans RM. Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell 1991 65 : 1255 66.
33. Mader S, Leroy O, Chen JY, Chambon P. Multiple parameters control the selectivity of nuclear receptors for their response elements: selectivity and promiscuity in the response element recognition by retinoic acid receptors and retinoid X receptors. J Biol Chem 1993 268 : 591 600.
34. Jho SH, Radoja N, Im MJ, Tomic-Canic M. Negative response elements in keratin genes mediate transcriptional repression and the cross-talk among nuclear receptors. J Biol Chem 2001 276 : 45914 20.
35. Davies RE. Effect of vitamin A on 7,12-dimethylbenz(a)an-thracene-induced papillomas in rhino mouse skin. Cancer Res 1967 27 : 237 41.
36. Harris CC, Sporn MB, Kaufman DG, Smith JM, Jackson FE, Saffiotti U. Histogenesis of squamous metaplasia in the hamster tracheal epithelium caused by vitamin A deficiency of benzo[a] pyrene Ferric oxide. J Natl Cancer Inst 1972 48 : 743 61.
37. Rogers AE, Herndon BJ, Newberne PM. Induction by dimethylhydrzine of intestinal carcinoma in normal rats and rats fed high or low levels of vitamin A. Cancer Res 1973 33 : 1003 9.
38. McCormick DL, Burns FJ, Albert RE. Inhibition of benz[a] pyrene-induced mammary carcinogenesis by retinyl acetate. J Natl Cancer Inst 1981 66 : 559 64.
39. Nauss KM, Bueche D, Newberne PM. Effect of vitamin A nutri-ture on experimental esophageal carcinogenesis. J Natl Cancer Inst 1987 79 : 145 7.
40. DeLuca LM, Tarone R, Huynh M, Jones CS, Chen LC. Dietary retinoic acid inhibits mouse skin carcinogenesis irrespective of age of initiation. Nutr Cancer 1996 25 : 249 57.
41. Hankin JH, Kolonel LN, Hinds MW. Dietary history methods for epidemiologic studies: application in a case-control study of vitamin A and lung cancer. J Natl Cancer Inst 1984 73 : 1417 22.
42. Mettlin CJ. Epidemiology of vitamin A and aerodigestive cancer. Adv Exp Med Biol 1992 320 : 21 6.
43. Moon RC. Vitamin A, retinoids and breast cancer. Adv Exp Med Biol 1994 364 : 101 07.
44. Guo Z, Nanus DM, Ruiz A, Rando RR, Bok D Gudas LJ. Reduced levels of retinyl esters and vitamin A in human renal cancers. Cancer Res 2001 61 : 2774 81.
45. Guo Z, Knudsen BS, Peehl DM, Ruiz A, Bok D, Rando RR, et al. Retinol metabolism and lecithin:retinol acyltransferase levels are reduced in cultured human prostate cancer cells and tissue specimens. Cancer Res 2002 62 : 1654 61.
46. Jeronimo C, Oliveria HR, Lobo F, Pais I, Teixeira MR, Lopes C. Aberrant cellular retinol binding protein 1 (CRBP1) gene expression and promoter methylation in prostate cancer. J Clin Pathol 2004 57 : 872 6.
47. Van Wauwe JP, Coene MC, Goossens J, Van Nijen G, Cools W, Lauwers W. Ketoconazole inhibits the in vitro and in vivo metabolism of all-trans-retinoic acid. J Pharmacol Exp Ther 1988 245 : 718 22.
48. Soprano DR, Qin P, Soprano KF. Retinoic acid receptors and cancers. Ann Rev Nutr 2004 24 : 201 21.
49. McGregor F, Wagner E, Felix D, Soutar D, Parkinson K, Harrison PR. Inappropriate retinoic acid receptor β expression in oral dyspla sia s: correlation with acqu isition of the immortal phenotype. Cancer Res 1977 57 : 3886 9.
50. Picard E, Seguin C, Momhoven N, Rochette-Egly C, Siat J, Borrelly J, et al. Expression of retinoid receptor genes and proteins in non-small-cell lung cancer. J Natl Cancer Inst 1999 91 : 1059 66.
51. Qiu H, Zhang W, El-Naggar AK, Lippman SM, Lin P, Lotan R, et al. Loss of retinoic acid receptor β expression is an early event during esophageal carcinogenesis. Am J Pathol 1999 155 : 1519 23.
52. Swisshelm K, Ryan K, Lee X, Tsou HC, Peacocke M, Sager R. Down-regulation of retinoic acid receptor β in mammary carcinoma cell lines and its up-regulation in senescing normal mammary epithelial cells. Cell Growth Differ 1994 5 : 133 41.
53. Zhang XK, Liu Y, Lee MO, Pfahl M. A specific defect in the retinoic acid response associated with human lung cancer cell lines. Cancer Res 1994 54 : 5663 9.
54. Lin B, Chen G, Xiao D, Lollure SK, Cao X, Su H, et al. Orphan receptor COUP-TF is required for induction of retinoic acid receptor, growth inhibition and apoptosis by retinoic acid in cancer cells. Mol Cell Biol 2000 20 : 957 70.
55. Wu Q, Li Y, Liu R, Agadir A, Lee MO, Liu Y, et al. Modulation of retinoic acid sensitivity in lung cancer cells through dynamic balance of orphan receptors nurr77 and COUP-TF and their heterodimerization. EMBO J 1997 16 : 1545 69.
56. Arapshian A, Kuppumbatti YS, Mira-y-Lopez R. Modulation of conserved CpG sites neighboring the beta retinoic acid response element may mediate retinoic acid receptor β gene silencing in MCF7 breast cancer cells. Oncogene 2000 19 : 4066 70.
57. Cote S, Sinnett D, Momparler RL. Demethylation by 5-aza-2′ deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor β gene in human colon carcinoma cells. Anticancer Drugs 1998 9 : 743 50.
58. Nakayama T, Watanabe M, Yamanaka M, Hirokawa Y, Suzuki H, Ito H, et al. The role of epigenetic modifications in retinoic acid receptor β2 gene expression in human prostate cancers. Lab Invest 2001 81 : 1049 57.
59. Cote S, Momparier RL. Activation of the retinoic acid receptor β gene by 5-aza-2′-deoxycytidine in human DLD-1 colon carcinoma cells. Anticancer Drugs 1995 8 : 56 61.
60. Sirchia SM, Ren M, Pili R, Siron E, Somenzi G, Ghidoni R, et al. Endogenous reactivation of the RAR?2 tumor suppressor gene epigenetically silenced in breast cancer. Cancer Res 2002 62 : 2455 61.
61. Hong WK, Endicott J, Itri LM, Doos W, Batsakis JG, Bell R, et al. 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med 1986 315 : 1501 5.
62. Lippman SM, Batsakis JG, Toth BB, Weber RS, Lee JJ, Martin JW, et al. Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. N Engl J Med 1993 328 : 15 20.
63. Stich HF, Hornby AP, Mathew B, Sankaranarayanan R, Nair MK. Response of oral leukoplakias to the administration of vitamin A. Cancer Lett 1988 40 : 93 101.
64. Han J, Jiao L, Sun Z, Gu QM, Scanlon KJ. Evaluation of N-4-(hydroxycarbophenyl) retinamide as a cancer prevention agent and as a cancer chemotherapeutic agent. In Vivo 1990 4 : 153 60.
65. Costa A, Formelli F, Chiesa F, Decensi A, de Paol G, Veronesi U. Prospects of chemoprevention of human cancers with the synthetic retinoid fenretinide. Cancer Res 1994 54 : 2032s 7s.
66. Lotan R, Xu XC, Lippman SM, Ro JY, Lee JS, Lee JJ, et al. Suppression of retinoic acid receptor β in premalignant oral lesions and its up-regulation by isotretinoin. N Engl J Med 1995 332 : 1405 10.
67. Misset JL, Mathe G, Santelli G, Gouveia J, Homasson JP, Sudre MC, et al. Regression of bronchial epidermoid metaplasia in heavy smokers with etretinate treatment. Cancer Detect Prev 1986 9 : 167 70.
68. Lippman SM, Kessler JF, Meyskens FL. Retinoids as preventive and therapeutic anticancer agents. Cancer Treat Rep 1987 71 : 391 405.
69. Kligman AM, Thorne EG. Topical therapy of actinic keratosis with tretinoin. In : Marks R, editor. Retinoids in cutaneous malignancy. Cambridge : Blackwell Scientific 1991. p 66 73.
70. Moriarty M, Dunn J, Darragh A, Lambe R, Brick I. Etretinate in treatment of actinic keratosis: A double blind crossover study. Lancet 1982 1 : 364 5.
71. Watson AB. Preventive effect of etretinate therapy on multiple actinic keratoses. Cancer Detect Prev 1986 9 : 161 5.
72. Kraemer KH, DiGiovanna JJ, Moshell AN, Tarone RE, Peck GL. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N Engl J Med 1988 318 : 1633 7.
73. Kraemer K, Di Giovanna JJ, Peck GL. Oral isotreinoin prevention of skin cancer in xeroderma pigmentosum: Individual variation in dose response. J Invest Dermatiol 1990 94 : 544.
74. Kelly JW, Sabto J, Gurr FW. Retinoids to prevent skin cancer in organ transplant recipients. Lancet 1991 338 : 1407.
75. Moon TE, Levine N, Cartmel B, Bangert JL. Retinoids in prevention of skin cancer. Cancer Lett 1997 114 : 203 5.
76. Greenberg ER, Baron JA, Stukel TA, Stevens MM, Mandel JS, Spencer SK, A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. N Engl J Med 1990 323 : 789 95.
77. Tangrea JA, Edwards BK, Taylor PR, Hartman AM, Peck GL, Salasche SJ, et al. Long term therapy with low-dose isotretinoin for prevention of basal cell carcinoma: A multicenter clinical trail. J Natl Cancer Inst 1992 84 : 328 32.
78. Graham V, Surwit ES, Weiner S, Meyskens FL. Phase II trial of beta-all-trans-retinoic acid for cervical intraepithelial neoplasia delivered via a collagen sponge and cervical cap. West J Med 1986 145 : 192 5.
79. Meyskens FL, Surwit E, Moon TE, Childers JM, Davis JR, Dorr RT, et al. Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial. J Natl Cancer Inst 1994 86 : 539 43.
80. Lawrence JA, Merino MJ, Simpson JF, Manrow RE, Page DL, Steeg PS. A high risk lesion for invasive breast cancer, ductal carcinoma in situ, exhibits frequent overexpression of retinoid X receptor. Cancer Epid Biomarkers Prevent 1998 7 : 29 35.
81. Elmore FL, Jain A, Siddiqui S, Tohidian N, Meyskens FL, Steele VE, et al. Development and characteristics of a human cell assay for screening agents for melanoma prevention. Melanoma Res 2005 17 : 42 50.
82. Papadimitrakopoulou VA, Hong WK. Biomolecular markers as intermediate end points in chemoprevention trials of upper aerodigestive tract cancer. Int J Cancer 2000 88 : 852 5.
83. Lippman SM, Shin DM, Lee JJ, Batsakis JG, Lotan R, Tainsky MA, et al. p53 and retinoid chemoprevention of oral carcino-genesis. Cancer Res 1995 55 : 16 19.
84. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 1999 96 : 8681 6.
85. Xu XC, Lee JS, Lee JJ, Morice RC, Liu X, Lippman SM, Nuclear retinoid receptor beta in bronchial epithelium of smokers before and during chemoprevention. J Natl Cancer Inst 1999 91 : 1317 21.
86. Widschwendter M, Berger J, Daxenbichler G, Muller-Holzner E, Widschwendter A, Mayr A, et al. Loss of retinoic acid receptor expression in breast cancer and morphologically normal adjacent tissues but not in the normal breast tissue distant from the cancer. Cancer Res 1997 57 : 4158 61.
87. Picard E, Seguin C, Momhoven N, Rochette-Egly C, Siat J, Borrelly J, et al. Expression of retinoid receptor genes and proteins in non-small-cell lung cancer. J Natl Cancer Inst 1999 91 : 1059 66.
88. Hoon DS, Spugnardi M, Kuo C, Huang SK, Morton DL, Taback B. Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients. Oncogene 2004 23 : 4014 22.
89. Seewaldt VL, Johnson BS, Parker MB, Collins SJ, Swisshelm K. Expression of retinoic acid β mediates retinoic acid-induced growth arrest and apoptosis in breast cancer cells. Cell Growth Differ 1995 6 : 1077 88.
90. Xu XC, Liu X, Tahara E, Lippman SM, Lotan R. Expression and up-regulation of retinoic acid receptor-beta is associated with retinoid sensitivity and colony formation in esophageal cancer cell lines. Cancer Res 1999 59 : 2477 83.
91. Hayashi K, Yokozaki H, Goodison S, Oue N, Suzuki T, Lotan R, et al. Inactivation of retinoic acid receptor β by promoter CpG hypermethylation in gastric cancer. Differentiation 2001 69 : 13 21.
92. Yang Q, Shan L, Yoshimura G, Nakamura M, Nakamura Y, Suzuma T, et al. 5-aza-2′-deoxycytidine induces retinoic acid receptor beta2 demethylation, cell cycle arrest and growth inhibition in breast carcinoma cells. Anticancer Res 2002 22 : 2753 6.
93. Mongan N P, Gudas LJ. Valproic acid, in combination with all-trans retinoic acid and 5-aza-2′-deoxycytidine, restores expression of RAR?2 in breast cancer cells. Mol Cancer Ther 2005 4 : 477 86.
94. Albanes D, Heinonen OP, Huttunen JK, Taylor PP, Virtamo J, Edwards BK, et al. Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha Tocopherol Beta-carotene Cancer Prevention Study. Am J Clin Nutr 1995 62 : 1425S 30S.
95. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, et al. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst 1966 88 : 1550 9.
96. Wang XD, Liu C, Bronson RT, Smith DE, Krinsky NI, Russell M. Retinoid signaling and activator protein-1 expression in ferrets given β-carotene supplements and exposed to tobacco smoke. J Natl Cancer Inst 1999 91 : 60 6.
97. McCormick DL, Johnsen WD, Rao KV, Bowman-Gram T, Steele VE, Lubet RA, et al. Comparative activity of N-(4-hydroxy-phenyl)-all-trans-retinamide and α-difluoromethylornithine as inhibitors of lymphoma induction in PIM transgenic mice. Carcinogenesis 1996 17 : 2513 7.
98. Wu K, Kim HT, Rodiquez JL, Munoz-Medellin D, Mohsin SK, Hilsenbeck SG, et al. 9-cis Retinoic acid suppresses mammary tumorigenesis in C3(1)-simian virus 40 T antigen-transgenic mice. Clin Cancer Res 2000 6 : 3696 704.
99. Wu K, Kim HT, Rodriquez JL, Hilsenbeck SG, Mohsin SK, Xu XC, et al. Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069. Cancer Epidemiol Biomarkers Prev 2002 11 : 467 74.
100. McCormick DL, Rao KV. Chemoprevention of hormone-dependent prostate cancer in the Wistar-Unilever rat. Eur Urol 1999 35 : 464 7.
101. Becci PJ, Thompson HJ, Strum JM, Brown CC, Sporn MB, Moon RC. N-butyl-N-(4-hydroxybutyl)nitrosamine-induced bladder cancer in C57BL/6 X DBA/2F1 mice as a useful model for study of chemoprevention of cancer with retinoids. Cancer Res 1981 41 : 927 32.
102. Curphey TJ, Kuhlmann ET, Roebuck BD, Longnecker DS. Inhibition of pancreatic and liver carcinogenesis in rats by retinoid- and selenium-supplemented diets. Pancreas 1988 3 : 36 40.
103. Ross DA, Kish P, Muraszko KM, Blaivas M, Srawderman M. Effect of dietary vitamin A or N-acetylcysteine on ethylnitrosurea-induced rat gliomas. J Neurooncol 1998 40 : 29 38.